MOCKA, SARA
MOCKA, SARA
SCIENZE DEL FARMACO E DELLA SALUTE (DSFS) (Department of Drug and Health Sciences)
3-Heteroarylcoumarins as Potential Therapeutic Agents for Neurodegenerative Diseases: Synthesis, Molecular Modeling and Biological Insights.
file da validare2025-01-01 Novás, M; Pereira, Cn; Mateos, La; López, Nb; Mocka, S; Crucitti, D; González, S; Viña, D; Matos, Mj.
Beyond conventional 5-Fluorouracil: Recent medicinal chemistry strategies to enhance its anticancer efficacy
file da validare2026-01-01 Mocka, Sara; Modica, Maria N.; Pittalà, Valeria; Salerno, Loredana; Romeo, Giuseppe; Marrazzo, Agostino; Siracusa, Laura; Intagliata, Sebastiano
Design development and in vitro evaluation of mutual prodrugs combining 5-fluorouracil and HO-1 inhibitor with antiproliferative effect.
file da validare2025-01-01 Mocka, S.; Salerno, L.; Pittalà, V.; Modica, M. N.; Romeo, G.; Consoli, V.; Sorrenti, V.; Schiano, M. E.; Albrizio, S.; Fiorino, F.; Magli, E.; Intagliata, S.
Development of 5-fluorouracil and heme oxygenase 1 inhibitor mutual prodrugs as an innovative anticancer strategy
file da validare2024-01-01 Mocka, S.; Salerno, L.; Pittalà, V.; Consoli, V.; Sorrenti, V.; Fiorino, F.; Magli, E.; Intagliata, S.
Development of dual A1/A2A adenosine receptor antagonists as nondopaminergic therapeutic agents for Parkinson’s disease
file da validare2025-01-01 Mocka, S; Mateos, La; López, Nb; Crucitti, D; Matos, Mj.
Exploring the Potential of 3-Heteroaryl-6/7-Hydroxycoumarins against Neurodegenerative Diseases: Synthesis, Characterization, Molecular Modelling and Preliminary Biological Results
file da validare2025-01-01 Novás, M; Pereira, Cn; Mateos, La; López, Nb; Mocka, S; Crucitti, D; González, S; Viña, D; Matos, Mj.
New mutual prodrugs of 5-fluorouracil and heme oxygenase 1 inhibitor with antiproliferative effects on breast cancer cells
file da validare2024-01-01 Mocka, S.; Salerno, L.; Pittalà, V.; Consoli, V.; Sorrenti, V.; Fiorino, F.; Magli, E.; Intagliata, S.
Synthesis of new 5-fluorouracil and heme oxygenase 1 inhibitor mutual prodrugs with antiproliferative effects.
file da validare2025-01-01 Mocka, S.; Salerno, L.; Pittalà, V.; Modica, M. N.; Consoli, V.; Sorrenti, V.; Sodano, F.; Schiano, M. E.; Vertuccio, S.; Albrizio, S.; Liuzzo, E.; Trapani, M.; Magli, E.; Intagliata, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 3-Heteroarylcoumarins as Potential Therapeutic Agents for Neurodegenerative Diseases: Synthesis, Molecular Modeling and Biological Insights. | 1-gen-2025 | Novás, M; Pereira, Cn; Mateos, La; López, Nb; Mocka, S; Crucitti, D; González, S; Viña, D; Matos, Mj. | file da validare |
| Beyond conventional 5-Fluorouracil: Recent medicinal chemistry strategies to enhance its anticancer efficacy | 1-gen-2026 | Mocka, Sara; Modica, Maria N.; Pittalà, Valeria; Salerno, Loredana; Romeo, Giuseppe; Marrazzo, Agostino; Siracusa, Laura; Intagliata, Sebastiano | file da validare |
| Design development and in vitro evaluation of mutual prodrugs combining 5-fluorouracil and HO-1 inhibitor with antiproliferative effect. | 1-gen-2025 | Mocka, S.; Salerno, L.; Pittalà, V.; Modica, M. N.; Romeo, G.; Consoli, V.; Sorrenti, V.; Schiano, M. E.; Albrizio, S.; Fiorino, F.; Magli, E.; Intagliata, S. | file da validare |
| Development of 5-fluorouracil and heme oxygenase 1 inhibitor mutual prodrugs as an innovative anticancer strategy | 1-gen-2024 | Mocka, S.; Salerno, L.; Pittalà, V.; Consoli, V.; Sorrenti, V.; Fiorino, F.; Magli, E.; Intagliata, S. | file da validare |
| Development of dual A1/A2A adenosine receptor antagonists as nondopaminergic therapeutic agents for Parkinson’s disease | 1-gen-2025 | Mocka, S; Mateos, La; López, Nb; Crucitti, D; Matos, Mj. | file da validare |
| Exploring the Potential of 3-Heteroaryl-6/7-Hydroxycoumarins against Neurodegenerative Diseases: Synthesis, Characterization, Molecular Modelling and Preliminary Biological Results | 1-gen-2025 | Novás, M; Pereira, Cn; Mateos, La; López, Nb; Mocka, S; Crucitti, D; González, S; Viña, D; Matos, Mj. | file da validare |
| New mutual prodrugs of 5-fluorouracil and heme oxygenase 1 inhibitor with antiproliferative effects on breast cancer cells | 1-gen-2024 | Mocka, S.; Salerno, L.; Pittalà, V.; Consoli, V.; Sorrenti, V.; Fiorino, F.; Magli, E.; Intagliata, S. | file da validare |
| Synthesis of new 5-fluorouracil and heme oxygenase 1 inhibitor mutual prodrugs with antiproliferative effects. | 1-gen-2025 | Mocka, S.; Salerno, L.; Pittalà, V.; Modica, M. N.; Consoli, V.; Sorrenti, V.; Sodano, F.; Schiano, M. E.; Vertuccio, S.; Albrizio, S.; Liuzzo, E.; Trapani, M.; Magli, E.; Intagliata, S. | file da validare |